- The worldwide rat model market is estimated to experience considerable growth in the upcoming years. This is due to innovations in gene editing tools. Rising immunology, oncology, and neurodegenerative disorders will also boost market revenues.
For Market Research Report on “Rat Model Market” Visit -http://www.grandviewresearch.com/industry-analysis/rat-model-market
Yet another factor that fuels the market is augmenting investments in the research of rat models. Organizations and governments are offering amenities so that rat model experiments can be conducted. In pre-clinical research and study, rats offer various advantages over rodent models.
These benefits comprise improved learning abilities, convenience of physiology monitoring, and rapid development of embryo-derived cells. They aid in behavioral study and cognitive research. Boosting preference for personalized medicines, which needs humanized rat models, is also likely to contribute shares to the rat model market.
Substitute market models include C.elegans, macaques, zebrafish, and marmosets. They are facing developments for utilization in research and pre-clinical testings. This is restraining the market.
On the basis of types, the market is segmented into conditioned, knockout, hybrid, immunodeficient, and out bred rat. The technologies segment is divided into embryonic stem cells, nuclear transferase, and microinjection. Due to increasing stem cell based research, embryonic stem cells would notice lucrative growth over the forecast period.
The services rat model market includes quarantine, cryopreservation, re-derivation, and genetic-testing. On the basis of applications, the market is split into toxicology, oncology, immunology, and CNS. Oncology will experience expansion over the forecast period. This is due to boosting cancer cases and demand for transgenic prognosis.
Major market regions are Latin America and MEA, North America, Asia Pacific, and Europe. In 2014, North America contributed the largest revenue. Due to promotion in initiatives for the treatment of chronic diseases, Europe was the largest rat model market in 2014.
Due to improving healthcare in the region, Asia Pacific is expected to observe significant growth in the years ahead. This is owing to stringent animal safety regulations in the region. China would contribute maximum demand for Asia Pacific. Prominent players in the rat model market are Biomedical Research Models, Inc., Harlan Laboratories, Inc., Janvier Labs, and SAGE Labs.
These players are busy implementing the strategy of partnerships with small organizations functioning in the segment.
Information Source: Grand View Research
To request a sample copy of this report, please complete the form below.
To purchase a copy of this report, please contact at
28 2nd Street, Suite 3036
San Francisco, CA 94105
Toll Free: 1-888-202-9519